摘要
目的:评价稳心颗粒治疗慢性肺心病合并冠心病心律失常的临床疗效。方法:将48例慢性肺心病合并冠心病随机分为两组:在常规控制肺部感染,吸氧,舒张支气管,扩血管减轻心脏负荷,改善心功能条件下,治疗组加用稳心颗粒9g,3次/日口服;对照组予地高辛0.125mg,1次/日口服。均以14天为1疗程。治疗期间监测两组的血压、心率、心功能、电解质及两组治疗前后的24小时动态心电图变化。结果:治疗组总有效率92。3%,对照组总有效率86.3%,两组总有效率比较差异有统计学意义(P<0。05)。结论:稳心颗粒治疗慢性肺心病合并冠心病心律失常的临床疗效肯定,不良发应小。
Objective：To evaluate Wenxinkeli the treatment of chronic pulmonary heart arrhythmia in the clinical efficacy of coronary heart disease.Methods：48 patients with chronic pulmonary heart with coronary artery disease were randomly divided into two groups：control lung infection in normal,oxygen,relaxation of bronchial,vasodilators reduce cardiac stress,improve heart function under the conditions of treatment group Wenxinkeli 9g tid orally;Control group received digoxin 0.125mg qd orally.Are 14 days for treatment.The two groups during treatment to monitor blood pressure,heart rate,cardiac function,electrolytes,and two groups before and after the 24-hour ambulatory ECG changes.Results：The total effective rate of 92.3% in the control group,the total efficiency of 86.3%,total effective rate between the two groups was statistically significant（P0.05）.Conclusion：The treatment of chronic lung Wenxinkeli heart arrhythmia in clinical coronary heart disease is effective and side effects.
